Search Results - "Pisanidis, N"

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 by Fountzilas, G., Dafni, U., Gogas, H., Linardou, H., Kalofonos, H. P., Briasoulis, E., Pectasides, D., Samantas, E., Bafaloukos, D., Stathopoulos, G. P., Karina, M., Papadimitriou, C., Skarlos, D., Pisanidis, N., Papakostas, P., Markopoulos, C., Tzorakoeleftherakis, E., Dimitrakakis, K., Makrantonakis, P., Xiros, N., Polichronis, A., Varthalitis, I., Karanikiotis, C., Dimopoulos, A. M.

“…Background: A randomized phase III trial in high-risk breast cancer patients was conducted, to further explore the impact of dose-density in the adjuvant…”
Get full text

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study by Kalofonos, H.P, Bamias, A, Koutras, A, Papakostas, P, Basdanis, G, Samantas, E, Karina, M, Misailidou, D, Pisanidis, N, Pentheroudakis, G, Economopoulos, T, Papadimitriou, C, Skarlos, D.V, Pectasides, D, Stavropoulos, M, Bafaloukos, D, Kardamakis, D, Karanikiotis, C, Vourli, G, Fountzilas, G

“…Abstract The primary objective was to compare the 3-year survival of rectal cancer patients randomised postoperatively to irinotecan (IRI), Leucovorin (LV) and…”
Get full text